Product Information
ARANESP 60 MCG/0.3 ML SYRINGE is a brand product labeled by Amgen Inc., priced at $1501.1639 per ML under NDC 55513002304. Its NADAC has been published 89 times since Nov 28, 2013.
Strength
60 ug/.3mL
Manufacturer
Amgen Inc.NDC
55513002304
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
DARBEPOETIN ALFAApproval Type
Biologic (BLA)
FDA Application
BLA103951On Market Since
8/14/2006
Pharmacological Classes
Price Statistics
The NADAC for ARANESP 60 MCG/0.3 ML SYRINGE has been published 89 times since Nov 28, 2013, and over the history we have for it it has risen 20.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1501.1639 per ML |
|---|---|
| All-time high | $1509.3000 (Jun 10, 2026) |
| All-time low | $1246.8902 (Nov 28, 2013) |
| 52-week high | $1509.3000 |
| 52-week low | $1501.1639 |
| Median price | $1484.3783 |
| Average price | $1432.3593 |
| Largest weekly change | +19.0% (Apr 17, 2024) |
| Weeks tracked | 89 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the darbepoetin alfa market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ARANESP 60 MCG/0.3 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for ARANESP 60 MCG/0.3 ML SYRINGE, manufactured by Amgen Inc., is $1501.1639 per ML (NDC 55513002304), effective Jun 24, 2026.
How has the price of ARANESP 60 MCG/0.3 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for ARANESP 60 MCG/0.3 ML SYRINGE has risen 20.4%. It has been tracked across 89 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ARANESP 60 MCG/0.3 ML SYRINGE?
Since Nov 28, 2013, the NADAC for ARANESP 60 MCG/0.3 ML SYRINGE has ranged from a low of $1246.8902 (Nov 28, 2013) to a high of $1509.3000 (Jun 10, 2026), with a median of $1484.3783 per ML.
Are there cheaper alternatives to ARANESP 60 MCG/0.3 ML SYRINGE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ARANESP 60 MCG/0.3 ML SYRINGE, so no direct lower-cost alternative is listed.
Who manufactures ARANESP 60 MCG/0.3 ML SYRINGE?
ARANESP 60 MCG/0.3 ML SYRINGE (NDC 55513002304) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification